Document is current
Any future updates will be listed below
-
Authors
Jensen, Sandra https://orcid.org/0000-0001-8662-0515
Tvedskov, Tove
Bechmann, Troels
Tramm, Trine
Jensen, Maj-Britt
Rahr, Hans
Lautrup, Marianne
-
Funding
Funding for this research was provided by:
Direktør Kurt Bønnelycke og Hustru fru Grethe Bønnelyckes Fond
Else og Mogens Wedell Wedellsborgs Fond
Syddansk Universitet
Region Syddanmark
Grosserer A.V. Lykfeldt og Hustrus Legat
- License Information
-
More Information
Article History
Received: 21 August 2025
Accepted: 21 August 2025
First Online: 12 September 2025
Disclosures
: Trine Tramm—honoraria for teaching material and lectures (Pfizer and Astra Zeneca) (2020–2025); honoraria for advisory boards on HER2-low and TDX-d (Astra Zeneca, Nov. 2024); honoraria for advisory boards on CDK4/6 inhibitors (Pfizer, Nov. 2020). Maj-Britt Jensen—advisory board, Novartis.
